Merck Acquiring Acceleron Pharma for Around $11.5B - NewsBreak
By Olachi in Business
Updated 3 years ago
Merck, the pharmaceutical giant with sizable operations in West Point, is acquiring Acceleron Pharma for around $11.5 billion, according to a staff report from CNBC. The move is broadening Merck's portfolio beyond the cancer drug Keytruda with potential treatments that could mean fresh revenue for the company.
